FDA Considers Changes To Obesity Drug Clinical Trials
The U.S. Food and Drug Administration will reconsider its clinical trial requirements for obesity drugs this week, and may add another step to the approval process for those treatments by requiring...To view the full article, register now.
Already a subscriber? Click here to view full article